When Ginkgo Bioworks went public last September the US biotechnology group proved as irresistible to investors as it had to the Wall Street banks that helped make the listing happen.
去年9月，当美国生物科技集团银杏生物工程(Ginkgo Bioworks)上市时，事实证明，这家公司对投资者的吸引力不亚于它对帮助其上市的华尔街银行的吸引力。
您已阅读3%（261字），剩余97%（9442字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。